Antibodies to tau and uses thereof
US9527909B2 · kind B2 · utility
3Cited by
20References
6Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Feb 18, 2016 |
| Grant date | Dec 27, 2016 |
| Priority date | — |
| Expiry date | Feb 18, 2036 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY10S424/80
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Monoclonal antibodies to human tau aggregate, compositions comprising such tau antibodies, and methods of using such tau antibodies for the treatment of neurodegenerative diseases including Alzheimer's disease, Progressive Supranuclear Palsy and Pick's disease.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.